Dr. Dana Upton provides broad experience in molecular genetics, cancer biology and immunology. Dr. Upton’s doctoral work at Wake Forest University in the Department of Cancer Biology focused on the mutagenic and replication blocking effects of the alcohol-derived DNA adduct N2-ethylguanine. Her postdoctoral work in the Department of Immunology at Duke University looked at the roles of activation-induced cytidine deaminase, polymerase beta, and DNA repair pathways in somatic hypermutation and class switch recombination in human B cells. At the University of North Carolina, Chapel Hill, Department of Microbiology and Immunology, Dr. Upton focused on the role of DNA repair during human papillomavirus replication. She has served as a biotechnology strategy and writing consultant for early stage companies, and was one of the leaders of the Wake Forest Biotechnology Case Competition and Conference. Dr. Upton is also an ASQ-certified Six Sigma Black Belt. In her free time, Dr. Upton enjoys baking, reading, and music.
Education: B.S. in Biology and A.B. in Chemistry from Duke University; Ph.D. in Molecular Genetics and Genomics with Certificate in Toxicology from Wake Forest University; MBA in Healthcare and Marketing from Wake Forest University.